🇺🇸 FDA
Patent

US 12178860

Hyaluronidase enzyme formulations for high volume administration

granted A61KA61K38/47A61K45/06

Quick answer

US patent 12178860 (Hyaluronidase enzyme formulations for high volume administration) held by HALOZYME, INC. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/47, A61K45/06, A61K9/0019